Herbas VPB

Print
EN | LT
LT - N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido tabletės forma, skirta panaudoti cistinės fibrozės gydymui
EN - Tablet formulation of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide for use in the treatment of cystic fibrosis

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 9/14 (2006.01)
A61K 31/47 (2006.01)
A61P 19/10 (2006.01)
A61P 19/00 (2006.01)
A61P 43/00 (2006.01)
A61K 45/06 (2006.01)
A61K 31/44 (2006.01)
European patent
(11) Number of the document 2464337
(13) Kind of document T
(96) European patent application number 10708442.8
Date of filing the European patent application 2010-02-18
(97) Date of publication of the European application 2012-06-20
(45) Date of publication and mention of the grant of the patent 2019-01-09
(46) Date of publication of the claims translation 2019-05-10
PCT application
(86) Number PCT/US2010/024609
Date 2010-02-18
PCT application publication
(87) Number WO 2011/019413
Date 2011-02-17
Priority applications
(30) Number Date Country code
US2009/000462 2009-08-13 WO
583066 2009-08-13 US
Inventors
(72)
ROWE, William, US
HURTER, Patricia, US
YOUNG, Christopher, R., US
DINEHART, Kirk, US
VERWIJS, Marinus, Jacobus, US
OVERHOFF, Kirk, US
GROOTENHUIS, Peter, D. J., US
BOTFIELD, Martyn, US
GROSSI, Alfredo, US
ZLOKARNIK, Gregor, US
VAN GOOR, Fredrick F., US
Grantee
(73) Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, MA 02210, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido tabletės forma, skirta panaudoti cistinės fibrozės gydymui
  Tablet formulation of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide for use in the treatment of cystic fibrosis
Last renewal fee
Payment date Validity (years) Amount
2025-02-03 16 347.00 EUR
Next renewal fee
2026-02-18